41 results
S-8
EX-5.1
XLO
Xilio Therapeutics Inc
1 Apr 24
Registration of securities for employees
4:25pm
, and originals, or copies certified to our satisfaction, of all pertinent records of the meetings of the board of directors and stockholders of the Company
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
1 Apr 24
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
4:15pm
and expenses payable by the company. The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing
8-K
EX-10.1
cuo9db5 uur61t
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-4.1
ngb6 rxyrmkva1
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-99.2
k0gs2xofhe
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
58dfmxl4d33g4spm1ci
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
S-3
oqw5q 4lm
9 Nov 22
Shelf registration
4:15pm
S-3
EX-4.5
wsn5yfsx5a 5ngyohiyu
9 Nov 22
Shelf registration
4:15pm
S-3
EX-4.4
00bf09j9vhbhd2m2
9 Nov 22
Shelf registration
4:15pm
S-3
EX-1.2
k2cgg1j hh
9 Nov 22
Shelf registration
4:15pm
DEF 14A
87zilnyvfufwbb8
26 Apr 22
Definitive proxy
4:05pm
S-8
EX-5.1
qz9h5dnt93pwu
1 Mar 22
Registration of securities for employees
5:20pm
10-K
s6o75t7
1 Mar 22
Annual report
4:07pm